Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia

E. Leitersdorf*, S. Eisenberg, O. Eliav, Y. Friedlander, N. Berkman, E. J. Dann, D. Landsberger, E. Sehayek, V. Meiner, M. Wurm, J. M. Bard, J. C. Fruchart -, Y. Stein

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

94 Scopus citations

Fingerprint

Dive into the research topics of 'Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science